Incyte
INCY
#1110
Rank
S$26.08 B
Marketcap
S$132.86
Share price
2.05%
Change (1 day)
32.48%
Change (1 year)

Incyte (INCY) - Total debt

Total debt on the balance sheet as of September 2025 : S$53.47 Million

According to Incyte's latest financial reports the company's total debt is S$53.47 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Incyte - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31S$59.18 M17.05%
2023-12-31S$50.56 M-9.02%
2022-12-31S$55.57 M-8.28%
2021-12-31S$60.59 M-3.64%
2020-12-31S$62.88 M-22.56%
2019-12-31S$81.19 M64.5%
2018-12-31S$49.35 M53.76%
2017-12-31S$32.1 M-96.6%
2016-12-31S$0.94 B7.53%
2015-12-31S$0.87 B-1.71%
2014-12-31S$0.89 B6.43%
2013-12-31S$0.83 B107.03%
2012-12-31S$0.40 B-1.11%
2011-12-31S$0.40 B8.32%
2010-12-31S$0.37 B-39.24%
2009-12-31S$0.62 B9.81%
2008-12-31S$0.56 B1.85%
2007-12-31S$0.55 B-2.25%
2006-12-31S$0.56 B-0.03%
2005-12-31S$0.56 B-7.88%
2004-12-31S$0.61 B116.76%
2003-12-31S$0.28 B-4.5%
2002-12-31S$0.29 B-10.04%
2001-12-31S$0.33 B1.94%
2000-12-31S$0.32 B97650.7%
1999-12-31S$0.33 M-74.79%
1998-12-31S$1.32 M
1996-12-31S$0.13 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Amgen
AMGN
S$70.73 B 132,177.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$0.58 B 992.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$55.08 B 102,903.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$78.85 B 147,349.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
S$0.15 B 195.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
S$0.26 B 403.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$41.49 B 77,497.11%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AVEO Oncology
AVEO
S$50.12 M-6.27%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
S$63.36 M 18.48%๐Ÿ‡บ๐Ÿ‡ธ USA